Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 18 fludarabine 7 Rituximab 7 Etoposide 7 Cytarabine 7 Radiotherapy 5 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 Filgrastim 5 Cyclosporine 4 Cisplatin 4 fludarabine phosphate 3 epratuzumab 3 Vincristine 3 Prednisone 3 Methylprednisolone 3 Indium 3 Immunotherapy, Adoptive 3 Doxorubicin 3 Dexamethasone 3 Busulfan 3 Antilymphocyte Serum 3 sargramostim 2 Radioimmunodetection 2 Paclitaxel 2 Mycophenolic Acid 2 Methotrexate 2 Lym-1 monoclonal antibody 2 Ifosfamide 2 Hydrocortisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Burkitt Lymphoma × veltuzumab × Clear all

NCT01279707 2014-07-14

MARALL

Queen Mary University of London

Phase 1/2 Unknown

Burkitt Lymphoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡